HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-08-29FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved a generic fixed-dose combination tablet of lamivudine and zidovudine under an Original Application (ANDA) by Macleods Pharm…
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring [Phase 1]
Phase 1 trial assessing safety and pharmacokinetics of a polyurethane Tenofovir Disoproxil Fumarate vaginal ring for HIV prevention; complet…
-
FDA approval · 2018-08-22FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals' generic fixed-dose combination emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) for treatment …
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial
Follow-up of Thai adults with breakthrough HIV infection after participating in a preventive HIV vaccine trial; results posted after complet…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients [Phase 2]
Phase 2 study evaluating a reduced-dose atazanavir in HIV-1 infected patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: Engagement to Care South Africa [NA]
Clinical trial update for Engagement to Care South Africa shows completion with results posted in 2018; study concerns HIV.
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Feasibility of Interventions on People Who Inject Drugs in Vietnam
A completed clinical trial in Vietnam assessed feasibility of interventions for people who inject drugs, with results posted in 2018.
-
FDA approval · 2018-08-07FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for STRIBILD, a fixed-dose combination HIV-1 therapy manufactured by Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects [Phase 4]
Phase 4 trial comparing darunavir/ritonavir + lamivudine versus darunavir/ritonavir + emtricitabine/tenofovir in treatment-naïve HIV-1 infec…
-
FDA approval · 2018-08-01FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for GENVOYA, the fixed-dose combination tablet of elvitegravir, cobicistat, emtricitabine, and tenof…
-
FDA approval · 2018-07-31FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Chartwell RX, LLC.)
FDA approved Tenofovir disoproxil fumarate tablets under an Original Application (ANDA) filed by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Community-based Interventions to Increase HIV Testing and HIV Care Utilization [NA]
A Kaiser Permanente trial evaluating community-based strategies to boost HIV testing and engagement in HIV care has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs) [NA]
Completed clinical trial evaluating technology-assisted treatment and relapse prevention for substance use disorders and HIV in Federally Qu…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Implementation of PrEP to HIV in Brazilian Transgender Women [Phase 4]
A Phase 4 clinical trial update discusses implementing pre-exposure prophylaxis (PrEP) for HIV prevention among Brazilian transgender women;…
-
FDA approval · 2018-07-30FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) submitted by Gilead Sciences, resulting in an updated lab…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals [Phase 4]
A Phase 4 clinical trial update assessing the immunogenicity and safety of the yellow fever vaccine in individuals infected with HIV.
-
CLINICAL_TRIALS research · 2018-07-30Clinical Trial Update: Regional Bone Turnover Using 18F-fluoride-PET/CT in HIV-1-infected Men: PETRAM Study
An ongoing clinical trial (PETRAM) using 18F-fluoride PET/CT to evaluate regional bone turnover in HIV-1-infected men.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Integrated Hypertension and HIV Care Cascades in Uganda
A Ugandan clinical trial evaluating integrated hypertension and HIV care cascades has completed.
-
FDA approval · 2018-07-27FDA Approved: TYBOST — Supplemental Application (Gilead Sciences, Inc.)
FDA has approved a supplemental application for TYBOST (cobicistat) submitted by Gilead Sciences, Inc.
-
CLINICAL_TRIALS research · 2018-07-27Clinical Trial Update: Point of Care Early Infant Diagnosis Patient Impact Study
A completed clinical trial evaluating the patient impact of point-of-care early infant HIV diagnosis.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis [Phase 2]
Phase II safety and acceptability study of an injectable pre-exposure prophylaxis product (TMC278LA) completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Engagement in HIV Primary Care Services
A completed clinical trial evaluating engagement in HIV primary care services among participants with HIV infection, including individuals w…
-
FDA approval · 2018-07-24FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for emtricitabine and tenofovir disoproxil fumarate from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2018-07-24FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Emtricitabine and Tenofovir Disoproxil Fumarate by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2018-07-24FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application to allow Mylan Pharmaceuticals to market a generic fixed-dose combination of emtricitabine and tenof…